Radiographers

  • STEP 1

    After you have logged in, navigate to the CPD Activities and Questionnaires tab where you will find the activities (as mentioned below) you have to complete.

    You will need 60 CEU’s for your audit to be compliant. A minimum of 10 CEU’s should be in the ethics category.

  • STEP 2

    Below is a list of all the activities available to complete.

    These cover a total of 111 CEU’s, and comprise 71 clinical, 17 ethics and 23 general CEU’s.

    1. If you already have a few CEU’s, complete any activities to make up for the CEU shortfall you need.

    OR

    1. If you currently have no CEU’s, complete any activities to make up for the 60 CEU’s you will need.

    HOWEVER, MAKE SURE THAT YOU COMPLETE THE MINIMUM REQUIRED ETHICS CEU’S

  • STEP 3

    When you have completed the necessary activities for your audit, please send an email or WhatsApp to notify us.

    (safocus@iafrica.com / 074 230 3874)

    We will confirm the correctness and then submit your CPD Individual Activity Record (IAR) on 29May2020 via email to the HPCSA and copy you in the email for your reference.

* Should you not finish before the 29th of May at 12h00 we will request for an extension on your behalf and send you an email with more details of the next steps.

Please contact us should you need more guidance.

CLINICAL
  • A1(20) – US assessment of sports-related hip injuries PART 1
  • A1(20) – US assessment of sports-related hip injuries PART 2
  • A2(20) – Bedside transcranial sonography monitoring in a patient with hydrocephalus post subarachnoid hemorrhage
  • A3(20) – Reliability of high-resolution ultrasound and magnetic resonance arthrography of the shoulder in patients with sports-related shoulder injuries
  • A4(20) – ABCDE of prehospital ultrasonography: a narrative review PART 2
  • A4(20) – ABCDE of prehospital ultrasonography: a narrative review PART1
  • A5(20) – ACUTE ABDOMEN systemic sonographic approach to acute abdomen in emergency department: a case series
  • A6(20) – Sonographic presentation of rice bodies in subacromial‑subdeltoid chronic bursitis
  • A7(20) – Which ultrasound transducer type is best for diagnosing pneumothorax?
  • A8(20) – The Area method: a new method for ultrasound assessment of diaphragmatic movement
  • A10(20) – Radiographic and CT Features of Viral Pneumonia – PART 1
  • A10(20) – Radiographic and CT Features of Viral Pneumonia – PART 2
  • A11(20) – Pictorial Review of Digital Radiography Artifacts
  • A12(20) – Evaluation of Kidney Stones with Reduced-Radiation Dose CT: Progress from 2011-2012 to 2015-2016 – Not There Yet
  • A13(20) – The use and pitfalls of intracranial vessel wall imaging: how we do it
  • A15(20) – Imaging of Kidney Cysts and Cystic Kidney diseases in Children: An international working group consensus statement
  • A16(20) – Imaging and Management of Blunt Cerebrovascular Injury PART 1
  • A16(20) – Imaging and Management of Blunt Cerebrovascular Injury PART 2
  • A17(20) – Multimedia-enhanced Radiology Reports: Concept, Components, and Challenges PART 1
  • A17(20) – Multimedia-enhanced Radiology Reports: Concept, Components, and Challenges PART 2
  • A19(20) – BRCA-associated Cancers: Role of Imaging in Screening, Diagnosis, and Management
  • A20(20) – Breast Cancer Risk and Mammographic Density Assessed with Semiautomated and Fully Automated Methods and BI-RADS
  • A21 (20) – Breast Cancer Tissue Markers, Genomic Profiling, and Other Prognostic Factors: A Primer for Radiologists PART 2
  • A21(20) – Breast Cancer Tissue Markers, Genomic Profiling, and Other Prognostic Factors: A Primer for Radiologists PART 1
  • A22(20) – Contrast controversies and confusion
  • A23(20) – Statistics 101 for Radiologists
  • A24(20) – Practical approaches to quality improvement for Radiologists
  • A25(20) – Screening mammography with special reference to guidelines in South Africa
ETHICS
  • PE1(20) Ethical guidelines on social media
  • PE1(19) – Advanced directives as a tool to respect patient’s values and preferences: discussion on the case of Alzheimer’s disease
  • PE2(19) – How technology impacts on the therapeutic relationship
  • PE3(20) – Digital pills: a scoping review of the empirical literature and analysis of the ethical aspects
  • PE5(20) – General ethical guidelines for good practice in telemedicine
GENERAL
  • G1(19) – Medicinal Cannabis: History, Pharmacology, And Implications for the Acute Care Setting
  • G1(20) Human trafficking – what the health care professional can do
  • G2(20) – Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
  • G2a(19) Update of cannabis and its medical use  History and Pharmacology Part 1 of 3
  • G2b(19) Update of cannabis and its medical use  Cannabis toxicity and dependence Part 2 of 3
  • G2c(19) Update of cannabis and its medical use  The use of cannabis for medical purposes Part 3 of 3
  • G3(20) – The psychological impact of quarantine and how to reduce it: rapid review of the evidence
  • G4(20) – Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study
  • G5(20) – Clinical management of suspected or confirmed COVID-19 disease